Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2025
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CDTX is no longer listed, so this page shows Q4 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 255
- +84 vs. Q3 2025
- Shares held
- 33.3M
- +888.0K (+2.7%) vs. Q3 2025
- Total value
- $7.36B
- +$4.25B (+136.9%) vs. Q3 2025
- New holders
- 139
- 63 more added
- Sold out
- 55
- 46 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CNH Partners LLC | 157,709 | $34.8M | 0.73% | +157,709 | New |
| Fred Alger Management, LLC | 164,575 | $36.4M | 0.14% | −338,302−67.3% | Reduced |
| Perceptive Advisors LLC | 165,131 | $36.5M | 0.67% | +165,131 | New |
| Northern Trust Corp | 179,081 | $39.6M | 0.01% | +28,913+19.3% | Added |
| Sofinnova Investments, Inc. | 180,265 | $39.8M | 1.72% | +126,068+232.6% | Added |
| Neuberger Berman Group LLC | 184,873 | $40.8M | 0.03% | +184,873 | New |
| Omni Event Management Ltd | 185,313 | $40.9M | 3.16% | +185,313 | New |
| Charles Schwab Investment Management Inc | 190,700 | $42.1M | 0.01% | +45,282+31.1% | Added |
| Norges Bank | 200,000 | $44.2M | 0.00% | +200,000 | New |
| Rock Springs Capital Management LP | 204,878 | $45.3M | 2.32% | −44,524−17.9% | Reduced |
| Vivaldi Asset Management, LLC | 205,233 | $45.3M | 2.74% | +205,233 | New |
| Bank of America Corp | 207,844 | $45.9M | 0.00% | −33,927−14.0% | Reduced |
| Alpine Associates Management Inc. | 208,560 | $46.1M | 3.10% | +208,560 | New |
| Verition Fund Management LLC | 210,329 | $46.5M | 0.25% | +210,329 | New |
| Alliancebernstein L.P. | 212,028 | $46.8M | 0.01% | +194,918+1,139.2% | Added |
| Polar Asset Management Partners Inc. | 216,998 | $47.9M | 0.95% | +216,998 | New |
| Marshall Wace, LLP | 222,763 | $49.2M | 0.05% | −12,547−5.3% | Reduced |
| Weiss Asset Management LP | 224,998 | $49.7M | 0.70% | +224,998 | New |
| Spruce Street Capital LP | 232,269 | $51.3M | 16.95% | +232,269 | New |
| Magnetar Financial LLC | 232,537 | $51.4M | 0.50% | +232,537 | New |
| Point72 Asset Management, L.P. | 250,000 | $55.2M | 0.09% | −1,328,069−84.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 263,332 | $58.2M | 0.09% | −186,668−41.5% | Reduced |
| Citadel Advisors LLC | 269,389 | $59.5M | 0.04% | −324,604−54.6% | Reduced |
| Ikarian Capital, LLC | 273,243 | $60.4M | 7.81% | −4,461−1.6% | Reduced |
| FMR LLC | 274,962 | $60.7M | 0.00% | −500,571−64.5% | Reduced |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 275,000 | $60.7M | 0.81% | +275,000 | New |
| JPMorgan Chase & Co | 276,551 | $61.1M | 0.00% | +245,880+801.7% | Added |
| Highland Capital Management Fund Advisors, L.P. | 279,900 | $61.8M | 4.31% | +279,900 | New |
| Squarepoint Ops LLC | 293,586 | $64.9M | 0.13% | +293,586 | New |
| Logos Global Management LP | 310,000 | $68.5M | 4.56% | −65,000−17.3% | Reduced |
| UBS Oconnor LLC | 315,474 | $69.7M | 1.86% | +315,474 | New |
| Citigroup Inc | 348,421 | $77.0M | 0.05% | +346,474+17,795.3% | Added |
| Qube Research & Technologies Ltd | 358,432 | $79.2M | 0.11% | +322,549+898.9% | Added |
| Goldman Sachs Group Inc | 377,718 | $83.4M | 0.01% | +107,714+39.9% | Added |
| Farallon Capital Management, L.L.C. | 382,800 | $84.6M | 0.44% | −125,200−24.6% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 455,978 | $100.7M | 1.08% | +38,428+9.2% | Added |
| Summit Partners Public Asset Management, LLC | 477,527 | $105.5M | 2.97% | +347,527+267.3% | Added |
| Millennium Management LLC | 509,647 | $112.6M | 0.08% | +321,364+170.7% | Added |
| Geode Capital Management, LLC | 520,591 | $115.0M | 0.01% | +116,477+28.8% | Added |
| Beryl Capital Management LLC | 522,138 | $115.3M | 11.69% | +522,138 | New |
| Morgan Stanley | 542,722 | $119.9M | 0.01% | +164,538+43.5% | Added |
| Pentwater Capital Management LP | 565,000 | $124.8M | 0.90% | +565,000 | New |
| Glazer Capital, LLC | 650,191 | $143.6M | 3.78% | +650,191 | New |
| Balyasny Asset Management LLC | 672,890 | $148.6M | 0.28% | +475,330+240.6% | Added |
| Paradigm Biocapital Advisors LP | 759,565 | $167.8M | 4.49% | −201,599−21.0% | Reduced |
| Jefferies Financial Group Inc. | 766,520 | $169.3M | 1.39% | +401,520+110.0% | Added |
| State Street Corp | 884,374 | $195.3M | 0.01% | +111,615+14.4% | Added |
| Vivo Capital, LLC | 956,670 | $211.3M | 13.66% | −354,755−27.1% | Reduced |
| Darwin Global Management, Ltd. | 997,196 | $220.2M | 4.46% | 00.0% | Unchanged |
| UBS Group AG | 1,074,924 | $237.4M | 0.05% | +601,370+127.0% | Added |
| FIL Ltd | 1,257,574 | $277.8M | 0.21% | +1,257,574 | New |
| HBK Investments L P | 1,260,000 | $278.3M | 3.01% | +1,260,000 | New |
| BlackRock, Inc. | 1,680,662 | $371.2M | 0.01% | +515,209+44.2% | Added |
| Vanguard Group Inc | 2,007,193 | $443.4M | 0.01% | +776,527+63.1% | Added |
| Ra Capital Management, L.P. | 3,365,523 | $743.4M | 7.62% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −3,020,990−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −1,414,165−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −946,788−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −682,901−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −585,000−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −487,233−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −396,015−100.0% | Sold out |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −307,960−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −292,657−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −227,272−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −220,902−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −216,219−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −177,523−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −157,320−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −152,325−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −138,091−100.0% | Sold out |
| Patient Square Capital LP | 0 | $0 | 0.00% | −121,000−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −109,704−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −79,012−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −75,743−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −65,895−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −61,081−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −53,333−100.0% | Sold out |
| Wasatch Advisors Inc | 0 | $0 | 0.00% | −51,310−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −31,398−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −29,806−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −22,027−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −21,403−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −20,532−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −17,465−100.0% | Sold out |
| West Michigan Advisors, LLC | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,604−100.0% | Sold out |
| Bank of Hawaii | 0 | $0 | 0.00% | −8,338−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| Jeppson Wealth Management, LLC | 0 | $0 | 0.00% | −6,155−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −5,926−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −4,315−100.0% | Sold out |
| Anb Bank | 0 | $0 | 0.00% | −3,187−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −2,867−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −2,649−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −2,635−100.0% | Sold out |